For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.
Our vision – value through innovation – has always characterized our collaborative work, and serves as the motive and the basis for our corporate principles. We recognize that our strength and competitive advantage are, in part, the result of our commitment to sustaining an organization that encourages diversity in all aspects of the business, whether that be in the diversity of the background of our employees, of thoughts and ideas, or in the diversity of our partners and suppliers.
